Postnatal thyroid hormone replacement in very preterm infants

Seminars in Perinatology

Volumn 25, Issue 6, 2001, Pages 417-425

  Kok, Joke H ^a,b   Briet, Judy M ^a   Van Wassenaer, Aleid G ^a  

^a EMMA CHILDREN S HOSPITAL   (Netherlands)

^b H3N ^*  (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

LIOTHYRONINE; LUNG SURFACTANT; PROTIRELIN; STEROID; THYROID HORMONE; THYROXINE;

BRAIN MATURATION; CLINICAL TRIAL; DRUG INDICATION; GESTATIONAL AGE; HORMONE SUBSTITUTION; HORMONE SYNTHESIS; HUMAN; HYPOPHYSIS THYROID SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; HYPOTHYROIDISM; POSTNATAL CARE; PREMATURITY; PRIORITY JOURNAL; REVIEW; THYROID FUNCTION; THYROID HORMONE BLOOD LEVEL; TREATMENT OUTCOME;

EID: 0035211131     PISSN: 01460005     EISSN: None     Source Type: Journal    
DOI: 10.1053/sper.2001.27550     Document Type: Article

References (65)

1. Detection of thyroid hormones in human embryonic cavities during the first trimester of pregnancy
2. Is neurophysiological development related to maternal hypothyroidism or to maternal hypothyroxinemia?
3. Materno-fetal transfer of thyroxine in congenital hypothyroidism due to a total organification defect or thyroid agenesis
4. Regulation of thyroid hormone metabolism during fetal development
5. Maturation of thyroid hormone and thyroid-stimulating hormone in the fetus
6. Ontogeny of iodothyronine deiodinases in human liver
7. Serum iodothyronines in the human fetus and the newborn: Evidence for an important role of placenta in fetal thyroid hormone homeostasis
8. Timing of vulnerability of the brain to iodine deficiency in endemic cretinism
9. The prenatal role of thyroid hormone evidenced by feto-maternal Pit-1 deficiency
10. Outcome of a baby born from a mother with acquired juvenile hypothyroidism having undetectable thyroid hormone concentrations
11. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child
12. Low maternal free T 4 concentrations during early pregnancy are associated with impaired psychomotor development in infancy
13. Neurological development in the newborn and young child in relation to maternal thyroid function
14. 5′-monodeiodinase activity in the developing human cerebral cortex
15. The type 2 iodothyronine deiodinase is expressed primarily in glial cells in the neonatal brain
16. The type 2 and type 3 deiodinase play important roles in coordinating development in rana catesbeiana tadpoles
17. Distinct thyroid hormone-dependent expression of TrkB and p75 ngfr in nonneural cells during the critical TH-dependent period of the cochlea
18. Ontogenis of hypothalamo-pituitary-thyroid function and metabolism in man, sheep, and rat
19. Thyroid development and disorders of the thyroid function in the newborn
20. Thyroid function in the preterm infant: A longitudinal assessment
21. Thyroid function in very preterm infants: Influences of gestational age and disease
22. Low thyroxinaemia occurs in the majority of very preterm newborns
23. Thyroid function in very preterm infants
24. Thyroid function and thyroid hormone requirements of very preterm infants
25. Maturation of human hypothalamic-pituitary-thyroid function and control
26. Fetal thyroid metabolism; a pluralistic system
27. Neonatal hypothyroxinemia: Effects of iodine intake and premature birth
28. Randomised trial of iodine intake and thyroid status in preterm infants
29. Free thyroxine levels in hospitalized newborns: Depressed levels in critical, nonthyroidal illness
30. Transient hypothyroidism in the newborn neonate
31. Thyroid complications, including overt hypothyroidism, related to the use of non-radiopaque silastic catheters for parenteral feeding in prematures requiring injection of small amounts of an iodated contrast medium
32. Hypothyroxinemia in premature infants: Is thyroxine treatment necessary?
33. New approaches to hormonal acceleration of fetal lung maturation
34. Thyroid hormone and the cardiovascular system: From theory to practice
35. Increased mortality in neonates with low thyroxine values
36. Low serum thyroxine on initial newborn screening is associated with intraventricular hemaorrhage and death in very low birth weight infants
37. Low thyroid hormones and respiratory-distress syndrome of the newborn
38. Thyroid function in respiratory distress syndrome of the newborn
39. Significance of transient postnatal hypothyroxinemia in premature infants with and without respiratory distress syndrome
40. Serum concentrations of thyrotropin, thyroid hormones and thyroid hormone-binding proteins during acute and recovery stages of idiopathic respiratory distress syndrome
41. Correlates of low thyroxine values at newborn screening among infants born before 32 weeks gestation
42. The relation of transient hypothyroxinemia in preterm infants to neurologic development at two years of age
43. Hypothyroxinemia of prematurity and the risk of cerebral white matter damage
44. Transient hypothyroxinemia associated with developmental delay in very preterm infants
45. The relation between neonatal thyroxine levels and the neurodevelopmental outcome at age 5 and 9 years in a national cohort of very preterm and/or very low birth weight infants
46. Low plasma triiodothyronine concentrations and outcome in preterm infants
47. Low triiodothyronine concentration in preterm infants and subsequent intelligence quotient (IQ) at 8 year follow up
48. Low serum thyroxine concentrations and neural maturation in preterm infants
49. Thyroid hormone for the prevention of neurodevelopmental impairment in preterm infants (Cochrane Review)
50. Effects of thyroxine supplementation on neurologic development in infants born at less than 30 weeks' gestation
51. Postnatal thyroxine supplemantation in infants less than 32 weeks' gestation: Effects on pulmonary morbidity
52. L-thyroxine treatment of preterm newborns: Clinical and endocrine effects
53. Results of controlled double-blind study of thyroid replacement in very low-birth-weight premature infants with hypothyroxinemia
54. Neonatal thyroxine supplementation in very preterm children: Developmental outcome evaluated at early school age
55. Motor nerve conduction velocity in very preterm infants in relation to thyroxine supplementation
56. Reduction of mortality rate in premature infants by substitution of thyroid hormones
57. The thyroid-system function in preterm infants of postmenstrual ages of 31 weeks or less: Evidence for a "transient lazy thyroid system"
58. Postnatal thyroxine administration for idiopathic respiratory distress syndrome in preterm infants
59. Postnatal triiodothyronine replacement and respiaratory distress syndrome of the preterm infant
60. Thyroid function in preterm newborns; is T4 treatment required in infants < 27 weeks' gestational age?
61. Crucial role for type II iodothyronine deiodinase in the metabolic coupling between glial cells and neurons during brain development
62. Thyroxine supplementation to infants of less than 30 weeks gestational age does not increase plasma triiodothyronine concentrations
63. Thyroxine administration to infants less than 30 weeks gestational age decreases plasma triiodothyronine concentrations
64. Changes in plasma thyroid hormone levels after a single dose of triiodothyronine in premature infants of less than 30 weeks gestational age
65. Thyroid function in very preterm infants, possible implications